Ignite Creation Date:
2025-12-24 @ 2:25 PM
Ignite Modification Date:
2026-01-01 @ 6:28 PM
Study NCT ID:
NCT01139359
Status:
WITHDRAWN
Last Update Posted:
2012-07-19
First Post:
2010-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma
Sponsor:
Alaunos Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-06
Start Date Type:
None
Primary Completion Date:
2011-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2011-06
Completion Date Type:
ESTIMATED
First Submit Date:
2010-06-04
First Submit QC Date:
None
Study First Post Date:
2010-06-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-07-18
Last Update Post Date:
2012-07-19
Last Update Post Date Type:
ESTIMATED